"Obesity" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A status with BODY WEIGHT that is grossly above the acceptable or desirable weight, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Descriptor ID |
D009765
|
| MeSH Number(s) |
C18.654.726.500 C23.888.144.699.500 E01.370.600.115.100.160.120.699.500 G07.100.100.160.120.699.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Obesity".
Below are MeSH descriptors whose meaning is more specific than "Obesity".
This graph shows the total number of publications written about "Obesity" by people in this website by year, and whether "Obesity" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 7 | 2 | 9 |
| 1997 | 6 | 6 | 12 |
| 1998 | 10 | 7 | 17 |
| 1999 | 15 | 2 | 17 |
| 2000 | 16 | 4 | 20 |
| 2001 | 15 | 1 | 16 |
| 2002 | 19 | 6 | 25 |
| 2003 | 35 | 9 | 44 |
| 2004 | 30 | 20 | 50 |
| 2005 | 35 | 10 | 45 |
| 2006 | 37 | 13 | 50 |
| 2007 | 32 | 13 | 45 |
| 2008 | 41 | 13 | 54 |
| 2009 | 41 | 12 | 53 |
| 2010 | 45 | 25 | 70 |
| 2011 | 60 | 24 | 84 |
| 2012 | 67 | 23 | 90 |
| 2013 | 91 | 42 | 133 |
| 2014 | 60 | 27 | 87 |
| 2015 | 61 | 27 | 88 |
| 2016 | 54 | 26 | 80 |
| 2017 | 65 | 21 | 86 |
| 2018 | 47 | 20 | 67 |
| 2019 | 43 | 19 | 62 |
| 2020 | 43 | 34 | 77 |
| 2021 | 35 | 48 | 83 |
| 2022 | 12 | 59 | 71 |
| 2023 | 16 | 52 | 68 |
| 2024 | 32 | 32 | 64 |
| 2025 | 38 | 12 | 50 |
| 2026 | 6 | 5 | 11 |
To return to the timeline,
click here.
Below are the most recent publications written about "Obesity" by people in Profiles.
-
Cardiometabolic Outcomes after Surgical Remission of Endogenous Hypercortisolism: A Prospective Cohort Study. J Clin Endocrinol Metab. 2026 May 19; 111(6):1613-1627.
-
Geroprotective effects of diet and exercise plus metformin in frail older veterans with obesity: The DEMFOS randomized trial protocol. Contemp Clin Trials. 2026 Jun; 165:108321.
-
Fructose: metabolic signal and modern hazard. Nat Metab. 2026 May; 8(5):1019-1033.
-
High-fat diet causes rapid loss of intestinal group 3 innate lymphoid cells through microbiota-driven inflammation and mitochondrial stress. Immunity. 2026 Apr 14; 59(4):988-1005.e9.
-
DXA-Derived Abdominal Adiposity and Obesity-Related Cancer Risk Among Postmenopausal Women in the Women's Health Initiative. Obesity (Silver Spring). 2026 May; 34(5):997-1009.
-
Designing Next-Generation Cardiometabolic Outcome Trials for Obesity Medicines. J Am Coll Cardiol. 2026 Apr 21; 87(15):1936-1949.
-
Community Participatory Co-Design and Development of a Digital Diabetes Prevention Education Program for Hispanic Families With Obesity: Mixed Methods Study. JMIR Form Res. 2026 Feb 11; 10:e67800.
-
Testosterone plus lifestyle therapy improves skeletal muscle glycolysis in older men with obesity and hypogonadism. Front Endocrinol (Lausanne). 2025; 16:1719749.
-
Myokine SIRPa exacerbates kidney disease in diabetes. JCI Insight. 2026 Feb 09; 11(3).
-
Pre-diagnostic body mass index trajectories and associations with lung cancer risk. Am J Epidemiol. 2026 Feb 05; 195(2):358-366.